PHARMANUTRA DRAFT FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS AT 31.12.2018

Related News

• PharmaNutra takes part int the Aim Italia...

  Great investor interest in the Company’s strategies during the virtual edition of the conference organised...

• Further Analysis of PharmaNutra in Market...

  Market Insight continues its in-depth study of PharmaNutra S.p.A. through interviews with Chairman and...

Related Products

• Cetilar

  Cetilar®, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis. Massages...

• Bonecal

  Bonecal is a nutritional supplement that contains algal Calcium, Vitamin K2 and Vitamin D3, which aid...